STEMI in Coronary Dissections. When Should We Do It and What Are Its Outcomes?

Courtesy of Dr. Carlos Fava.

Generally, coronary artery dissection (SCAD) is not very frequent in young women and presents better evolution with medical treatment. However, it is occasionally associated with ST segment elevation. In this scenario, PCI with stent implantation is quite challenging.

infarto peri-procedimiento

The study looked at 4298 STEMI patients; 53 presented SCAD (1.23%).

STEMI-SCAD patients tended to be younger, were mostly women, had better BMI and fewer heart disease risk factors, but also had 2 times more cardiogenic shock (18.9% vs. 9.1% p=0.002).

13% of MI-SCAD patients were pregnant.


Read also: MitraClip in the Real World: Mid-Term Progress.


The culprit artery in this group was often the left main or the anterior descending.

Revascularization rate was lower also in this group: 70% vs. 97% (p<0.001). 31 patients received PCI with stent, 3 patients PCI with balloon and other 3 CABG.

The need for PCI was associated to cardiogenic shock, left main dissection, proximal dissection or TIMI flow 0-1.

PCI success was 91%. In addition, they received more stenting, and with longer stents.


Read also Is Complete Revascularization the Right Choice in Acute Myocardial Infarction with Multivessel Disease?


Survival at 3 years was higher in the STEMI-SCAD group: 97% vs. 84% (p<0.001).

Conclusion

STEMI-SCAD represents an important group, particularly among young women, characterized by presenting a compromised left main and cardiogenic shock more often, compared against STEMI-atherosclerosis. PCI is successful in most of these patients, with low mortality at 3 years.

Courtesy of Dr. Carlos Fava.

Original title: Revascularization in Patients With Spontaneous Coronary Artery Dissection and ST-Segment Elevation Myocardial Infarction.

Refernce: Angie S. Lobo, et al. J Am Coll Cardiol 2019;74:1290–300.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...